United States Cardiac Output Monitoring Market Report 2019-2025
DUBLIN, March 28, 2019 /PRNewswire/ -- The "Cardiac Output Monitoring Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.
With ongoing improvements in reading accuracy, it is expected that the non-invasive and minimally invasive technologies will drive growth in the ICU and ER market, while cannibalizing the procedural volume of PAC treatments in the OR. Over the forecast period, the minimally and non-invasive monitoring segments will continue to grow, motivated in part by demand-driven product advancements.
Modern non-invasive technologies are greatly improved and have become more widely accepted as an alternative to invasive CO monitoring in some settings. Cardiac output (CO) refers to the volume of blood being pumped by the heart. Monitoring of patient cardiac output is rapidly becoming a standard of care and a vital part of early diagnosis and treatment. It is also important in the management of heart attacks and for monitoring of sepsis patients.
The inclusion of cardiac output monitoring in treatments provides valuable information on the volume tissue perfusion and oxygen delivery. Low cardiac output indicates that there is insufficient circulation and potential starvation of vital internal organs.
Key Topics Covered:
1. Executive Summary
U.S. Patient Monitoring Equipment Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History
Research Methodology
2. Cardiac Output Monitoring Market
2.1 Introduction
2.1.1 The Fick Principle
2.1.2 Dilution Methods
2.1.3 Doppler Ultrasound Methods
2.1.4 Pulse Pressure Methods
2.1.5 Other Methods
2.2 Market Overview
2.3 Market Analysis And Forecast
2.3.1 Total Pulmonary Artery Catheter Market
2.3.1.1 Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market
2.3.1.2 Specialty Pulmonary Artery Catheter Market
2.3.2 Total Minimally Invasive Cardiac Output Monitoring Market
2.3.2.1 Minimally Invasive Cardiac Output Monitor Market
2.3.2.2 Minimally Invasive Cardiac Output Sensor Market
2.3.3 Total Non-Invasive Cardiac Output Monitoring Market
2.3.3.1 Non-Invasive Cardiac Output Monitor Market
2.3.3.2 Non-Invasive Cardiac Output Sensor Market
2.4 Drivers And Limiters
2.5 Competitive Market Share Analysis
3. Abbreviations
4. Appendix: Company Press Releases
4.1 Introduction
4.2 Press Releases
4.2.1 Draeger Medical
4.2.1.1 First half of 2018: Drger increases net sales
4.2.1.2 New HealthTrust Agreement Covers Drger's Line of Anesthesia Solutions
4.2.1.3 Drger and ICON Prepared to Support Hospitals with Ventilators During Times of Crisis
4.2.1.4 Drger First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems
4.2.1.5 Drger Infinity M300 Monitor Now Features FIPS Security
4.2.1.6 Drger First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems
4.2.1.7 Drger to Discuss Alarm Management and Strategies for Eliminating Alarm Fatigue at HIMSS16
4.2.2 Edwards Lifesciences
4.2.2.1 Edwards Lifesciences Reports Second Quarter Results
4.2.2.2 Edwards' Acumen Hypotension Prediction Index Launches In The U.S.
4.2.2.3 Edwards Lifesciences Reports Fourth Quarter Results
4.2.2.4 Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
4.2.2.5 Edwards Acquires Harpoon Medical
4.2.2.6 Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
4.2.2.7 Edwards Lifesciences Reports Fourth Quarter Results
4.2.2.8 Edwards Lifesciences Completes Acquisition Of Valtech Cardio
4.2.2.9 Edwards Receives CE Mark For Hypotension Probability Indicator
4.2.2.10 Edwards Lifesciences Reports Second Quarter Results
4.2.2.11 Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors
4.2.2.12 Edwards Lifesciences Reports First Quarter Results
4.2.2.13 Steven Loranger Appointed To Edwards Lifesciences Board Of Directors
4.2.2.14 Edwards Lifesciences Reports Fourth Quarter Results
4.2.3 Fukuda Denshi
4.2.3.1 Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. A High Performance Color Portable Ultrasound Unit Designed for a Wide Array of Specialty Markets
4.2.3.2 Hospitals, Healthcare Providers to Save with the Fukuda Denshi USA Inc. and Amerinet Choice License and Supply Agreement
4.2.4 GE Healthcare
4.2.4.1 GE Healthcare Introduces Virtual Reality Training for Healthcare Technology Management Professionals
4.2.4.2 GE Healthcare and FitTrace announce collaboration to offer body composition analysis software for sports and fitness markets
4.2.4.3 GE Healthcare and Preventice Solutions Collaborate to Extend the Heart Station Beyond the Hospital
4.2.4.4 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion
4.2.4.5 GE Healthcare, Ferozsons L.L. and P&SHD collaborate to deliver comprehensive training program for Maternal, Newborn & Child Health (MNCH)
4.2.4.6 Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom's healthcare sector
4.2.4.7 GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
4.2.4.8 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years
4.2.4.9 GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology
4.2.4.10 Catherine Estrampes appointed President & CEO of GE Healthcare Europe
4.2.4.11 GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes
4.2.4.12 Emmanuel Ligner named President and CEO of GE Healthcare Life Sciences
4.2.4.13 GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
4.2.4.14 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
4.2.4.15 Refurbished Parts for GE Diagnostic Imaging Equipment Now Available from GE Healthcare
4.2.4.16 Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey
4.2.4.17 GE to help transform over 200 hospitals in Egypt with 700 units of its advanced healthcare technologies
4.2.4.18 GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare
4.2.4.19 Boston Children's Hospital and GE Healthcare Working Together to Create Smart Imaging Technology to Better Detect Pediatric Brain Disorders
4.2.4.20 GE Healthcare showcases industry-first technologies and digital solutions, focused on improving outcomes, at RSNA 2016
4.2.4.21 GE Healthcare Taps Into $28 Billion Orphaned IP Market With Stake in Pilot Lite Ventures
4.2.4.22 UC San Francisco and GE Healthcare Launch Deep Learning Partnership to Advance Care Globally
4.2.4.23 Exploring digital solutions to combat heart disease
4.2.4.24 The OR Goes Digital: New Apps Drive Operational and Economic Outcomes
4.2.4.25 GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea
4.2.4.26 See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians
4.2.4.27 GE to invest 150 million in biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT
4.2.4.28 Boosting Compact Ultrasound IQ: GE Healthcare's New Vivid iq Combines Power and Portability
4.2.4.29 GE Healthcare launches next generation Biacore(TM) molecular interaction analysis platform
4.2.4.30 GE Healthcare and Uppsala BIO form a new partnership
4.2.4.31 Charles Koontz Appointed President and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer
4.2.5 Honeywell Life Sciences
4.2.5.1 Honeywell Incorporates Integrated Video Capability Into Telehealth Platform Allowing Healthcare Professionals To Treat Patients In Their Homes
4.2.5.2 Honeywell Unveils New Version of FDA-Cleared Telehealth Software
4.2.5.3 Honeywell Presents Its Latest Connected Technologies That Help Reduce Clinical Errors At Saudi Health Exhibition
4.2.5.4 Honeywell Hosts Annual Investor Conference; Reaffirms First Quarter And Full-Year 2016 Outlook; Targets 2017 Core Organic Sales Up 4-5%
4.2.6 Masimo
4.2.6.1 New Study Investigates Impact of General Ward Clinical Monitoring Using Masimo Root, Radius-7, and Patient SafetyNet on Clinical Workflow and Patient Care
4.2.6.2 New Study Investigates the Utility of Masimo PVi as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery
4.2.6.3 Masimo Announces Vital Signs Check Application for the Root Patient Monitoring and Connectivity Platform
4.2.6.4 New Study Investigates the Utility of Masimo ORi (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation
4.2.6.5 United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97 Pulse CO-Oximeters with Eve
4.2.6.6 Masimo and PositiveID Announce the U.S. Release of TIR-1
4.2.6.7 New Study Investigates the Utility of Masimo SedLine Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
4.2.6.8 New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
4.2.6.9 Women's Tennis Association to Use Masimo MightySat Fingertip Pulse Oximeters to Advance Player Health and Performance
4.2.6.10 New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb in Reducing Unnecessary Blood Transfusions
4.2.6.11 Masimo SET Pulse Oximetry Helps Form Basis of Utah Senate Resolution on Postoperative Oxygen Saturation Home Monitoring for Patients Prescribed Opioids
4.2.6.12 Masimo Reports First Quarter 2018 Financial Results
4.2.6.13 New Study Investigates the Utility of Masimo SpHb in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
4.2.6.14 Masimo Announces CE Marking of Rad-97 Pulse CO-Oximeter with Integrated NomoLine Capnography
4.2.6.15 Masimo Announces UniView
4.2.6.16 New Study Investigates the Performance of Masimo SpHb During Acute Bleeding and After Fluid Resuscitation
4.2.6.17 Masimo Announces Replica
4.2.6.18 Leading Nephrology Care Center in India Adopts Masimo Technologies Across Continuum of Care
4.2.6.19 New Study Evaluates the Performance of Masimo SpHb in Monitoring Pediatric Trauma Patients
4.2.6.20 New Study Evaluates the Performance of Masimo PVi as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients
4.2.6.21 Masimo Announces CE Marking of Eve CCHD Newborn Screening Application for the Rad-97 Pulse CO-Oximeter
4.2.6.22 Masimo Announces FDA Clearance of Next Generation SedLine Brain Function Monitoring
For more information about this report visit
https://www.researchandmarkets.com/research/ztrl6r/united_states?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article